Interestingly, in pancreatic cancer, Ral guanine nucleotide-exchange factors (Ral GEFs) have emerged as the key effectors of the K-Ras pathway instead of the B-Raf, extracellular signal-regulated kinase (ERK) or MAPK pathways. Here, KRAS is linked to pancreatic neoplasm.